Zurcher Kantonalbank (Zurich Cantonalbank) - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$533,359
-53.9%
14,021
+10.3%
0.00%
-60.0%
Q2 2023$1,157,972
+50.6%
12,711
+9.0%
0.01%
+25.0%
Q1 2023$769,160
+39.9%
11,661
+9.6%
0.00%
+33.3%
Q4 2022$549,936
-30.0%
10,635
-7.6%
0.00%
-40.0%
Q3 2022$786,000
+66.9%
11,515
+10.6%
0.01%
+66.7%
Q2 2022$471,000
-20.3%
10,408
-10.5%
0.00%0.0%
Q1 2022$591,000
-8.5%
11,627
-14.9%
0.00%0.0%
Q4 2021$646,000
+168.0%
13,669
+86.8%
0.00%
+200.0%
Q3 2021$241,000
-47.8%
7,316
+0.2%
0.00%
-66.7%
Q2 2021$462,000
+49.0%
7,303
+1.1%
0.00%
+50.0%
Q1 2021$310,000
-33.3%
7,221
-11.1%
0.00%
-33.3%
Q4 2020$465,000
+89.8%
8,1260.0%0.00%
+50.0%
Q3 2020$245,000
-7.5%
8,1260.0%0.00%0.0%
Q2 2020$265,000
+108.7%
8,126
+71.4%
0.00%
+100.0%
Q1 2020$127,000
+2.4%
4,741
+17.3%
0.00%0.0%
Q4 2019$124,000
+117.5%
4,041
+69.5%
0.00%
Q3 2019$57,000
-24.0%
2,384
-19.0%
0.00%
-100.0%
Q2 2019$75,000
+108.3%
2,944
+59.6%
0.00%
Q1 2019$36,000
-5.3%
1,845
-36.4%
0.00%
Q4 2018$38,000
+90.0%
2,903
+159.7%
0.00%
Q3 2018$20,0001,1180.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders